That’s why the study highlighted in this article, which demonstrates that a new vaccine reduced the rate of tuberculosis in HIV-positive people by 39%, is so important in both fighting tuberculosis and AIDS. Usually HIV-positive individuals cannot get a TB vaccine because the bacteria could re-activate in a weak immune system (for a similar article from last year, read here or here).
“Development of a new vaccine against tuberculosis is a major international health priority, especially for patients with HIV infection,” Ford von Reyn, director of the DarDar International Programs for the Section on Infectious Disease and International Health at Dartmouth Medical School, said.
AIDSTanzania 